NCT01370512
Droxidopa / Pyridostigmine in Orthostatic Hypotension
Enrolling by Invitation
PHASE2Ages 18+InterventionalTreatmentMayo ClinicInvestigator-initiated
~30 participants
Updated 2026-07-15 on ClinicalTrials.gov
What's tested:DroxidopaPyridostigminePlacebo
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in orthostatic diastolic blood pressure
Measured over 1 hour after medication administration, 2 hours after medication administration
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Wolfgang Singer, M.D. · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Change in orthostatic diastolic blood pressure1 hour after medication administration, 2 hours after medication administration
diastolic blood pressure measured upon standing reported in mm/Hg